In practical terms, the measurement of cystatin C-based estimated GFR, which remains unaffected by medications inhibiting creatinine secretion, may assist in distinguishing nephrotoxicity from pseudo-acute kidney injury (9). This evidence concerns the gene CST3 and acute kidney injury.